Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Micellar Paclitaxel for Severe Psoriasis
NCT00006276Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Sep 2000
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of paclitaxel in psoriasis, sponsored by National Cancer Institute. Primary endpoint: Percent Change in Psoriasis Area and Severity Index at 24 weeks. Started Sep 2000; status: completed.
02
Drugs
paclitaxel
03
Conditions
psoriasis
Beyond the preview
Go deeper on NCT00006276.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006276.